Bjoerna Berning
0000-0003-3364-0314
1 paper found
Refreshing results…
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
Missing publications? Search for publications with a matching author name.